Factors to guide the use of extended-release buprenorphine formulations for specific patient populations-Reference-Cited by-同舟云学术

Factors to guide the use of extended-release buprenorphine formulations for specific patient populations

Published:2023-02-08 Issue: Volume: Page:1-7
ISSN:1465-9891
Container-title:Journal of Substance Use
language:en
Short-container-title:Journal of Substance Use

Author:

Cuperfain Ari B.¹^ORCID,Katznelson Gali²,Costa Tianna³,Wong Patrick³,Beyraghi Narges¹³,George Tony P.¹³^ORCID,Lofwall Michelle R.⁴,Chopra Nitin¹³

Affiliation:

1. Department of Psychiatry, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada

2. Department of Obstetrics and Gynaecology, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada

3. Addictions Division and Centre for Complex Interventions, Centre for Addiction and Mental Health, University of Toronto, Toronto, Ontario, Canada

4. Departments of Behavioral Science and Psychiatry, Center on Drug and Alcohol Research, University of Kentucky College of Medicine, Lexington, Kentucky, USA

Funder

no funding

Publisher

Informa UK Limited

Subject

Health (social science),Medicine (miscellaneous)

Link

https://www.tandfonline.com/doi/pdf/10.1080/14659891.2023.2174908

Reference46 articles.

1. Tracing the affordances of long-acting injectable depot buprenorphine: A qualitative study of patients’ experiences in Australia

2. Management of opioid use disorders: a national clinical practice guideline

3. Factors of Interest in Extended-Release Buprenorphine: Comparisons Between Incarcerated and Non-Incarcerated Patients with Opioid Use Disorder

4. Perceptions and experiences toward extended-release buprenorphine among persons leaving jail with opioid use disorders before and during COVID-19: an in-depth qualitative study

5. Subcutaneous Buprenorphine Extended-Release Use Among Pregnant and Postpartum Women

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Feasibility and effectiveness of extended-release buprenorphine (XR-BUP) among correctional populations: a systematic review;The American Journal of Drug and Alcohol Abuse;2024-06-28

2. Buprenorphine extended-release injection (Brixadi®) in the management of opioid use disorder: a profile of its use in the USA;Drugs & Therapy Perspectives;2024-02

3. Initiation of Extended-release Depot Buprenorphine in a Patient Subject to a Community Treatment Order for Both Antipsychotic and Opioid Agonist Treatments;Journal of Addiction Medicine;2023-08-10